THE WHAT? Hims & Hers Health reported 38% year-on-year revenue growth in Q2 2026 and raised its full-year sales outlook, supported by accelerating US growth, international expansion and a growing subscriber base.
THE DETAILS Q2 revenue increased to US$753.2 million, from US$544.8 million a year earlier, while subscribers grew 19% to nearly 2.9 million. US revenue rose 16% to US$621.8 million, while international revenue surged to US$131.4 million, supported by the acquisition of Eucalyptus in June. Monthly revenue per average subscriber increased 21% to US$92. However, the company recorded a net loss of US$86.3 million, compared with net income of US$42.5 million a year earlier, while adjusted EBITDA declined to US$60.3 million. Hims & Hers now expects Q3 revenue of US$880 million to US$900 million and has raised its FY26 revenue guidance to US$3.1 billion-US$3.3 billion.
THE WHY? The results highlight Hims & Hers’ rapid expansion in the consumer health and wellness market as it scales internationally and invests in an AI-enabled, doctor-led healthcare platform. Rising subscriber numbers and higher spend per subscriber are supporting top-line growth, although the decline in profitability highlights the investment required to support that expansion.
Source: Business Wire
